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ABSTRACT
Rapid detection is essential for the elimination and control of tuberculosis (TB) worldwide. Our study aimed to 
show the current and actual patterns of human and bovine TB distribution in the Greater Cairo Area community by the 
application of different TB diagnostic tools to individuals and farm animals with suspected TB. Both sputum and blood 
specimens were collected from 150 suspected human cases in the community. Sputum samples were examined using 
direct microscopy (Ziehl-Neelsen stain), culture on Lowenstein-Jensen medium, and real-time PCR. Blood samples 
were used for interferon gamma release assay (IGRA). In addition, lymph nodes and blood samples were collected from 
57 tuberculin-positive animals. Lymph nodes were examined using direct microscopy (Ziehl-Neelsen stain), culture 
on Lowenstein-Jensen medium, and real-time PCR. Animal blood samples were also tested with IGRA. Sensitivity 
and specificity as well as positive and negative predictive values were calculated for all tests. The results showed that 
for both human and animal samples, IGRA provided the most accurate estimates of current TB infection compared 
to other tests. Furthermore, IGRA had the highest sensitivity and was the most convenient, proving its superiority 
compared to traditional methods in showing true levels of TB dissemination. This work shows that IGRA is a powerful 
tool for detection of TB in suspected humans and farm animals and should be incorporated into routine TB screening 
programs, which require more than one test. 
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ABSTRAK
Pengesanan pantas adalah penting untuk penghapusan dan pengawalan tuberkulosis (TB) di seluruh dunia. Kajian 
kami bertujuan untuk menunjukkan corak terkini dan sebenar taburan TB manusia dan bovin di komuniti kawasan 
Kaherah Besar dengan penerapan alat diagnostik TB yang berbeza kepada individu dan haiwan ternakan yang 
disyaki TB. Kedua-dua spesimen kahak dan darah dikumpulkan daripada 150 kes manusia yang disyaki dalam kalangan 
masyarakat. Sampel kahak diperiksa menggunakan mikroskopi langsung (stain Ziehl-Neelsen), kultur pada medium 
Lowenstein-Jensen dan PCR masa nyata. Sampel darah digunakan untuk asai pelepasan gama interferon (IGRA). 
Sebagai tambahan, nodus limfa dan sampel darah dikumpulkan daripada 57 haiwan positif tuberkulin. Nodus limfa 
diperiksa menggunakan mikroskopi langsung (stain Ziehl-Neelsen), dikultur pada medium Lowenstein-Jensen dan 
PCR masa nyata. Sampel darah haiwan juga diuji dengan IGRA. Kesensitifan dan kekhususan serta nilai ramalan positif 
dan negatif dihitung untuk semua ujian. Hasil kajian menunjukkan bahawa untuk sampel manusia dan haiwan, IGRA 
memberikan anggaran yang paling tepat mengenai jangkitan TB semasa berbanding dengan ujian lain. Selanjutnya, 
IGRA mempunyai kesensitifan tertinggi dan paling mudah, membuktikan keunggulannya dibandingkan dengan 
kaedah tradisi dalam menunjukkan tahap penyebaran TB yang sebenarnya. Kertas ini menunjukkan bahawa IGRA 
adalah alat penting untuk mengesan TB pada manusia dan haiwan ternakan yang disyaki dan harus dimasukkan 
ke dalam program pemeriksaan rutin TB, yang memerlukan lebih daripada satu ujian.
Kata kunci:  Asai pelepasan gama interferon; Mesir; Mycobacterium species; PCR masa-nyata TB
InTRODuCTIOn
Tuberculosis (TB) is one of the most resilient infectious 
diseases globally, despite the existence of a live attenuated 
vaccine (BCG) as well as several potent antimicrobials 
(Issar 2003). Detection of Mycobacterium tuberculosis 
infection is of great importance for the elimination and 
control of TB worldwide; however, the existing screening 
methods are still limited (Ai et al. 2016). The world 
Health Organization (wHO) reports that approximately 
2-3 billion people in the world are latently infected with 
M. tuberculosis, and 5%-15% of these people will develop 
active disease during their lifetime. In egypt, the incidence 
of TB is estimated at 15 per 100,000 population per 
year. Accordingly, TB is considered to be the third most 
786 
important communicable disease problem in egypt, after 
schistosomiasis and hepatitis C, despite the low levels of 
HIV infection (wHO 2015).
Mycobacterium tuberculosis complex (MTBC) is a 
group of genetically related pathogens that cause TB in 
mammals. M. tuberculosis and M. bovis are the most 
common human- and animal-adapted strains, respectively 
(Gordon & Marcel 2015). M. tuberculosis may cause 
active or latent TB infection. The latter is a reservoir for 
future epidemics, as many risk factors may lead to the 
development of active disease including malnutrition, 
acute infections, or decreased immunity. M. bovis is 
a pathogen of significant importance in livestock and 
farm animals. It is also known to cause zoonotic TB in 
humans, raising concerns regarding the zoonotic risk for 
those living at the animal-human interface (Müller 2009). 
Zoonotic transmission of these pathogens occurs through 
close contact with infected cattle or consumption of 
contaminated animal products such as unpasteurized milk 
(Ayele et al. 2004; Cosivi et al. 1998; Müller et al. 2013). 
In Africa, although bovine TB is prevalent, effective 
disease control-including regular milk pasteurization and 
slaughterhouse meat inspection-is largely absent (Cosivi 
et al. 1998).
The identification of people with latent TB infection 
(LTBI) is one of the first priorities of TB control programs 
(Broekmans et al. 2002) to prevent development of active 
disease (Anderson et al. 2000). There is no gold standard 
for the detection of LTBI, although the tuberculin 
skin test (TST), which uses purified-protein derivative 
(PPD), is available (Lalvani 2007). The TST has many 
limitations, as the PPD antigens used for the TST are also 
present in the BCG vaccine strain, and false positive tests 
are thus common. Additionally, immunocompromised 
patients give false negative results and repeated visits 
are needed, rendering it inconvenient for screening large 
number of patients or screening farm animals (American 
Thoracic Society 2000).
 The conventional sputum smear microscopy method 
of detection remains the only diagnostic tool available in 
some high-burden countries, and although it can detect 
60%-80% of culture-positive TB cases under optimal 
conditions, the sensitivity is as low as 10%-30% in 
HIV-positive populations. In addition, it cannot be used 
to distinguish between various members of the family 
Mycobacteriaceae (Patama et al. 2009). Detection of 
Mycobacteria spp. using the conventional culture method 
is tedious and time consuming, and the decontamination 
process presents additional obstacles.
novel methods for the detection of mycobacteria 
that can provide results within 1-2 days and be performed 
directly on sputum and other clinical samples are 
continuously being developed (Hassan et al. 2014). 
Interferon gamma (IFn-γ) release assay (IGRA) is an in 
vitro measurement of the cell-mediated immune response 
to M. tuberculosis infection. If re-exposed, lymphocytes 
previously exposed to M. tuberculosis-specific antigens 
release IFn-γ, which can be measured as a method of 
detecting TB infection (past or current) (Mazurek et al. 
2010). IGRAs overcome many drawbacks of the TST, 
including enhanced specificity and ease of application 
(Gormley et al. 2004).
Our study compares different diagnostic tools to 
reveal the most reliable method for detection of the 
current distribution rates of TB in the egyptian community. 
Application of a reliable and powerful diagnostic tool 
will lead to the prompt choice and initiation of the most 
appropriate antimicrobial therapy.
MATeRIALS AnD MeTHODS
STATeMenT OF eTHICAL APPROVAL
Sample collection and all experiments were conducted in 
accordance and approval of the Safety and Occupational 
Health Committee of the Faculty of Pharmacy at Cairo 
university, Cairo, egypt, which approved the protocol as 
a whole and the sample collection schemes (Approval # 
MI 1370, 27th May 2015). All specimens had previously 
been collected by routine monitoring laboratories, and no 
direct contact was made between any of the authors and 
any human or animal subjects.
 A total of 150 sputum (three consecutive samples 
taken in the morning then pooled) and blood samples were 
collected from 150 suspected human cases as follows: 
80 community patients (HIV and cancer patients and 
samples from hospital laboratories), 50 casual contacts 
(health care workers in clinics and laboratories) and 20 
people who had contact with farm animals (farm workers, 
veterinarians, slaughter house workers). In addition, 57 
lymph node (Ln) samples and 57 blood samples were 
collected from tuberculin-positive animals just before 
slaughter.
 All samples were collected during the period from 
March 2016 to March 2017 in locations distributed within 
the Greater Cairo Area. Great Cairo is a large urban area 
that comprises Cairo-the capital of egypt-Giza, Helwan, 
Shoubra el Kheima and all of their surrounding suburbs. 
The population of the Greater Cairo Area exceeds 20 
million. Human sputum samples were prepared and 
examined using direct microscopy after Ziehl-neelsen 
staining (Zn smear), culture on Lowenstein-Jensen (LJ) 
media, and real-time PCR. Human blood samples were 
used for detection of interferon gamma release. For the 
animal subjects, both lymph nodes and blood samples 
were collected from 57 tuberculin-positive animals. 
Lymph nodes were examined using direct microscopy, 
culture and real-time PCR, and blood samples were tested 
using IGRA.
DIReCT MICROSCOPy AnD CuLTuRe TeCHnIque 
A direct smear was done after staining with Ziehl-
neelsen stain for the 150 sputum samples from persons 
with suspected TB, and a digestion-decontamination 
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procedure was then performed on every sputum specimen. 
LJ slants were inoculated with 3 drops of neutralized 
sediment. The cultured tubes were examined daily for a 
week then once per week for 6-8 weeks (Petroff 1915). 
Regarding the animal samples, the infected lymph 
nodes of 57 tuberculin-positive cows were prepared for 
direct microscopy and culture on LJ media as previously 
described (Marks 1972; Ratledge & Stanford 1982).
MOLeCuLAR DeTeCTIOn OF MyCOBACTeRIuM 
TuBeRCuLOSIS COMPLeX uSInG ReAL-TIMe PCR  
A The total collection of 150 sputum samples from persons 
with suspected TB, in addition to the infected Ln 
samples of 57 tuberculin-positive cows, were examined 
using real-time PCR. Preparation of animal Ln samples 
was done as previously described (ward et al. 1995), and 
then DnA extraction was done following the instructions 
of the extraction kit (Sigma Aldrich, uSA). Real-time 
PCR was performed to detect the MBTC as previously 
described using the MTplex dtec-RT-qPCR test kit 
(Edifici-Quórum3, Spain) (Ben Kahla et al. 2011). The 
kit comprises a series of species-specific targeted reagents 
designed for detection of all species contained in the 
MBTC. The genomic marker was the repetitive element 
IS6110, the PCR product size was 254 bp, and the 
forward primer 5´-CGTGAGGGCATCGAGGTGGC-3´ and 
reverse primer 5’- GCGTAGGCGTCGGTGACAAA-3’ were 
used as previously described (Van et al. 1991). The specific 
primers used to detect M. bovis were the forward primer 
5’-CAGGGATCCACCATGTTCTTAGCGGGTTG-3’ and 
reverse primer 5’-TGGCGAATTCTTACTGTGCCGGGGG 
-3’ as previously described (Jiang et al. 2006), 
while  the specif ic  primers used to detect  M. 
tuberculosis (human type) were the forward primer 
5’-GCCTCGAACAATCCGGeGTTGACAA’3 and reverse 
primer 5’-GAGGCATTAGCACGCTGTCAATC-3’.
  extracted DnA from the suspected samples was 
subjected to real-time PCR. The reaction volume consisted 
of 10 µl Hot Start-Mix qPCR 2×, 1 µl MTplex dtec-
qPCR-mix, 5 µl of DnA sample, and Dnase/Rnase-free 
water to 20 µl. The reaction conditions consisted of one 
cycle of 95 ºC for 5 min followed by 45 cycles of 95 ºC 
for 30 s and 60 ºC for 60 s for hybridization, extension, 
and data collection. The reaction was run in an Applied 
Biosystem StepOne Real-time PCR System (Applied 
Biosystem, uSA), and FAM fluorogenic signal was 
collected and the cycle threshold (CT) of the reactions 
was detected by StepOne™ software version 2.2.2 (Life 
Technology, uSA). The CT was defined as 10 times the 
standard deviation of the mean baseline fluorescence 
emission calculated for PCR cycles 3-15. For a sample to 
be considered positive, the corresponding amplification 
curve had to exhibit three distinct phases (geometric, 
linear, and plateau) that characterize the progression of 
the PCR reaction.
IGRA
Sample The 150 whole blood samples from suspected 
human cases were subjected to the quantiFeROn-TB-
Gold In-Tube assay (qFT-GIT) (Cellestis Ltd, Victoria, 
Australia) as follows. A blood sample was collected 
into 3 tubes; the first tube was coated with TB-specific 
antigens, the second with heparin-negative control, and 
the third with mitogen (phytohaemagglutinin) as positive 
control. Blood was incubated overnight at 37 °C. Plasma 
was then separated to measure the concentration of IFn-γ 
by enzyme-linked immunosorbent assay using the qFT- 
GIT assay (Cellestis Ltd, Victoria, Australia) according 
to the manufacturer’s instructions (Abu-Taleb et al. 2011).
Animal blood samples were subjected to the M. bovis 
gamma interferon test kit for cattle, Bovigam (Prionics, 
Germany), as follows. For each sample, 5 mL of blood 
was collected into heparinized blood-collecting tubes. 
Samples were transported to the laboratory within 12 
h. Aliquots of 1.5 mL of heparinized blood from each 
sample were dispensed into 24-well tissue culture trays. 
An aliquot of 100 µl of PBS (nil antigen control), avian 
PPD (purified protein derivative) or bovine PPD were 
added to the appropriate 3 wells containing the tested 
blood. The tissue culture trays containing blood and 
antigens were incubated for 16-24 h at 37 °C. Plasma was 
then separated to measure the concentration of IFn-γ by 
enzyme-linked immunosorbent assay using the Bovigam 
kit (Prionics, Germany) following the manufacturer’s 
instructions.
FInAL DIAGnOSIS
The final diagnosis was obtained from the patient´s 
medical record. It was made on the basis of all 
clinical, radiological, microbiological, and pathological 
information gathered.
STATISTICAL AnALySIS
Sensitivity, specificity, positive predicted value (PPV), 
and negative predicted value (nPV) were calculated for 
each diagnostic test, compared to the final diagnosis of 
TB. Statistical calculations were performed to compare 
the sensitivity and specificity of the TB detection methods.
ReSuLTS
MICROSCOPIC eXAMInATIOn, CuLTuRe, ReAL-TIMe PCR 
AnD IGRA OF HuMAn AnD AnIMAL SAMPLeS 
As shown in Table 1, the microscopic examination of 
150 human sputum samples collected from persons with 
suspected TB showed that 37 samples (25%) harbored 
the acid-fast bacilli. The culture method yielded 43 
isolates of Mycobacterium spp. (29%), while real-time 
PCR detected 49 positive cases (33%), which were 
identified as MBTC. Results of IGRA showed that 59 
blood samples (39%) were positive for TB.
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On the other hand, microscopic examination of 
lymph node of infected animals showed that 31 samples 
(54%) harbored the acid-fast bacilli, while the culture 
method yielded 37 isolates of Mycobacterium spp. (65%) 
after 6-8 weeks of incubation, and real-time PCR and 
IGRA detected 53 samples (93%) that were positive for 
M. bovis (Table 1). 
In both human and animal subjects, all positive 
TB samples detected by the conventional methods 
(microscopy and culture) were also detected as positive 
using real-time PCR and IGRA.
SAMPLe DIVeRSITy
As for the diversity of the 49 real-time PCR-positive 
human isolates (+ve MBTC), the results of species-specific 
PCR showed that 46 isolates belonged to the human type 
(M. tuberculosis), while 3 isolates were identified as M. 
bovis (Table 2). Only Mycobacetrium tuberculosis isolates 
were detected in community patients (31/80; 39%) and 
casual contacts (14/50; 28%). Both M. tuberculosis and 
M. bovis were isolated from farm animal workers (4/20; 
20%), where M. tuberculosis represented 1/20 (5%) and 
M. bovis represented 3/20 (15%) of the isolates.
For animal samples, all of the 53 real-time PCR-
positive isolates (+ve MTBC) were identified as M. bovis, 
as shown in Table 2.
TABLe 1.  Detection of Mycobacterium species using different diagnostic tools
Source
no. of samples Bacteriological findings Molecular 
findings
Blood based 
Assay findings
Microscopy Culture Real-time  PCR IGRA
no. of isolates 
(%)
no. of 
isolates (%)
no. of isolates 
(%)
no. of isolates 
(%)
H
um
an Sputum 150 37(24.67) 43 (28.67) 49 (32.67) -
Blood 150 - - - 59 (39.33)
A
ni
m
al
 sa
m
pl
es Lymph nodes 57 tuberculin+ 31 (54.39) 37 (64.91) 53 (92.98) -
Blood 57 tuberculin + - - - 53 (92.98)
STATISTICAL AnALySIS
when diagnostic tests were applied to the samples of the 
study group, the results were distributed as shown in 
Table 3. The sensitivity and specificity of the Zn smears 
were 74% and 100%, respectively. In addition, the Zn 
smear had a PPV of 100% and an nPV of 88.5%. Culture 
on LJ medium had sensitivity and specificity of 84% and 
99%, respectively, and PPV and nPV of 97.67% and 
92.52%, respectively. Real-time PCR had a sensitivity 
of 92% and specificity of 97%, a PPV of 93.88%, and 
an nPV of 96.04%. IGRA had a sensitivity of 96%, a 
specificity of 89%, PPV of 81.36% and nPV of 97.8%.
Fifty cases were diagnosed as TB patients according 
to patients’ medical records, of which 48 tested positive 
and 2 negative by IGRA, 37 positive and 13 negative by 
Zn smear, 42 positive and 8 negative by LJ culture, and 
46 positive and 4 negative by real-time PCR. Meanwhile, 
11 out of 100 participants diagnosed as non-TB patients 
were IGRA positive and 3 were real-time PCR-positive.
Regarding animal samples, the results were distributed 
as shown in Table 4. The sensitivity of the Zn smears 
was 54%, culture sensitivity was 65%, and real-time PCR 
and IGRA both had a sensitivity of 93%.
TABLe 2. Diversity of human and animal samples
Source
Human samples
Total no. of 
samples
no. of +ve LTB cases 
using real-time PCR 
(%)
no. of 
M. tuberculosis (%)
no. of 
M. bovis (%)
Community patients 80 31(39) 31 (100) 0
Casual contacts 50 14(28) 14 (100) 0
Farm animals contacts 20 4 (20) 1(25) 3(75)
Total 150 49(32.67) 3
Animal samples
Total 57 53(93) 0 53(100)
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TABLe 3. Sensitivities, specificities, PPVs and nPVs of Zn smear, culture, real-time PCR and IGRA tests in TB suspected human 
patients recruited in this study, n = 150
Method of 
diagnosis
negative (%) Positive 
(%)
Sensitivity 
%
Specificity 
%
PPVa, 
%
nPVa, 
%
Zn Smear b 113 (75.33) 37 (24.67) 74 100 100 88.5
Culture c 107 (71.33) 43 (28.67) 84 99 97.67 92.52
Real-time 
PCR d
101 (67.33) 49 (32.67) 92 97 93.88 96.04
IGRA e 91 (60.67) 59 (39.33) 96 89 81.36 97.8
Diagnosis f 100 (66.67) 50 (33.33)
TABLe 4.  Sensitivity of Zn smear, culture, real-time PCR and IGRA tests in tuberculin positive animals’ samples n=57
Method of 
diagnosis
negative Positive Sensitivity
Zn smear 26 31 54.39 %
Culture 20 37 64.91 %
Real-time PCR 4 53 92.98 %
IGRA 4 53 92.98%
a PPV, Positive predictive value; NPV, Negative predictive value. b Smears of respiratory samples were stained by Ziehl neelsen method for the 
detection of AFB (mycobacteria species). c Lowenstein Jensen’s media was used for mycobacteria culture of respiratory samples. d Real-time 
PCR = Real-time polymerase chain reaction targeting both the multicopy target IS6110 insertion element and a common genomic subsequence on 
respiratory samples. e IGRA = Interferon gamma releasing assay in whole blood performed in suspected active TB patients to detect the exposure 
to MTB (results above the cutoff 0.35 Iu/ml were considered as positive). f Final diagnosis taken from patient´s medical record.
DISCuSSIOn
The objective of the present study was to estimate the 
expediency of an IFn-γ assay for the rapid detection of 
mycobacterial TB infection in suspected individuals 
and farm animals and to conduct a comparative study 
between conventional, molecular methods and IGRA to 
identify the most appropriate method for detecting TB 
distribution in the Greater Cairo Community. Sputum 
and blood samples were collected from a total of 150 
suspected individuals. Sputum samples were examined 
using traditional methods. Blood samples were used 
for detection of gamma interferon release using the 
quantiFeROn-TB-Gold In-Tube assay (qFT-GIT). In 
addition to the human samples, lymph nodes and blood 
samples were collected from 57 tuberculin-positive 
animals. Lymph nodes were examined using microscopy 
and culture and the results confirmed by real-time PCR, 
while blood samples were tested for IGRA using the 
Bovigam assay. 
In both human and bovine subjects, IGRA was able 
to detect higher percentages of TB infection cases than 
conventional methods or real-time PCR. All cases of TB 
detected by the conventional methods (microscopy with 
Zn stain and culture) were positive using real-time PCR 
and IGRA.
The prevalence of LTBI caused by M. tuberculosis 
among the high-risk community patients as well as 
health care workers (Table 2) was similar to that found in 
previous studies carried out in egypt and the Middle east 
(el-Sokkary et al. 2015; Hiban & Hasan 2015). Such 
levels of infection prevalence are relatively high despite 
the relatively low rates of HIV infection and show that 
a standard program for detection and treatment of LTBI 
should be encouraged in the Middle east.
M. bovis (bovine TB) infections were detected 
in 15% (3/20) of subject with farm animals contact 
(Table 3). This is in agreement with previous studies 
and confirms the need for control programs to prevent 
and screen human infections resulting from animal 
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encounters (Cosivi et al. 1998; Hiban & Hasan 2015; 
Taylor et al. 2007). The viability of M. bovis in animal 
organs is essential for the isolation of mycobacteria by 
culture-based methods. The viability may be reduced 
by either freezing/unfreezing practices or by treatment 
with the selected decontaminant reagent, which is not 
completely innocuous for M. bovis. In addition, many 
factors influence the success of primary isolation of M. 
bovis from clinical specimens, including the culture media 
used, the decontamination procedures, and how samples 
are obtained and handled.
Although the isolation of mycobacteria and their 
identification based on phenotypical characters, 
particularly culture, has been used as a gold standard, 
these traditional methods are time consuming; 
consequently, their use is on the decline and they 
are being replaced by other diagnostic tools. In our 
study, the results obtained from real-time PCR showed 
that molecular methods are more sensitive than the 
conventional methods and have the additional advantage 
of being rapid (Taylor et al. 2001; Thoen et al. 2006). 
As for IGRA, it has high reliability and reproducibility, 
minimizes direct handling of samples cultures, has no 
cross reactivity with BCG, and does not have a boost effect 
because it is an in vitro assay (unlike TST) (Bianchi et 
al. 2009). IGRA also has some of the same advantages of 
molecular methods. 
In the case of examining farm animals for bovine 
TB, IGRA has various advantages including increased 
sensitivity and objective test procedures. More 
importantly, the test eliminates the need for a second 
visit to the farm and only requires 1-2 days, making it 
more rapid than culture and TST. However, IGRA also 
has drawbacks: it cannot distinguish between active 
and latent TB, it cannot be used for extrapulmonary TB 
diagnosis, it needs laboratory infrastructure, and its cost 
is high.
Comparing different detection methods, Zn smear 
had the highest specificity (100%) but the lowest 
sensitivity (74%). This may be due to its inability to 
detect less than 5,000-10,000 AFB per mL of specimen 
(de waard & Robledo 2007). Therefore, if only Zn smear 
is used, TB patients may not be diagnosed, resulting in 
more complications for the patient and transmission of 
disease in the community (de Kantor et al. 1998). In 
addition, Zn smear cannot distinguish between MTB 
and other mycobacterial species (de waard & Robledo 
2007), eliminating its use as a sole method of detection.
The culture method has a higher specificity than 
real-time PCR and IGRA (99%) but lower sensitivity 
(84%). False negative results obtained by culture in 8/50 
TB cases (16%) may be due to LJ culture contamination 
resulting in culture loss (de kantor et al. 1998).
 Real-time PCR has a sensitivity of 92% and 
specificity of 97%. Real-time PCR was negative in 
4/50 TB cases (8%); this might be due to the uneven 
distribution of bacilli in the sample, bad sampling, or 
suboptimal DnA extraction (Tortoli & Palomino 2007). 
In non-TB patients, real-time PCR was positive in 3/100 
cases (3%); this false positivity may be due to laboratory 
contamination (Ani et al. 2009).
 IGRA has the highest sensitivity at 96%, and a 
specificity of 89%. False negative IGRA results were 
obtained in 2/50 TB patients (4%). One of them was 
positive by real-time PCR, indicating that the patient 
might have weak T-cell response due to severe disease 
or might have been immunocompromised (Ravn et al. 
2005). The other false negative sample was negative 
by real-time PCR as well and might have been sub-
optimally processed or stored. The IGRA positive 
results in 11/100 non-TB cases may indicate LTBI in 
these patients. Thus, patients with positive IGRA results 
need follow-up to avoid developing active TB. These 
11 samples were not detected by Zn smear or real-time 
PCR, and 10 out of the 11 samples were not detected by 
culture. This might indicate poor quality of respiratory 
specimens, as reported by the wHO (de Kantor et al. 
1998).
COnCLuSIOn
IGRA is the method of choice for TB detection, as it 
was able to provide an accurate estimate of current 
TB infection rates among humans and animals in the 
examined community. IGRA can replace conventional 
methods for detection of TB, especially in countries like 
egypt where BCG vaccination is a national policy. It 
can be used for the detection of TB in farm animals as 
well. It has the advantage of being easy, rapid, precise, 
highly sensitive and convenient.
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